Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC

/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...

Related Keywords

United States ,American ,Joyce Allaire ,Pierre Kyme ,Exchange Commission ,Lifesci Advisors ,Armata Pharmaceuticals Inc ,Innoviva Inc ,Innoviva Strategic Opportunities ,Nasdaq ,Prnewswire Armata Pharmaceuticals Inc ,Armata Pharmaceuticals ,Annual Report ,Sci Advisors ,Nc ,